These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34596727)

  • 21. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
    Higashi MK; Veenstra DL; Kondo LM; Wittkowsky AK; Srinouanprachanh SL; Farin FM; Rettie AE
    JAMA; 2002 Apr; 287(13):1690-8. PubMed ID: 11926893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms.
    Bryk AH; Wypasek E; Plens K; Awsiuk M; Undas A
    Vascul Pharmacol; 2018 Jul; 106():22-27. PubMed ID: 29432897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement.
    Zhong SL; Liu Y; Yu XY; Xu D; Tan HH; Lin QX; Yang M; Lao HY; Lin SG
    Eur J Clin Pharmacol; 2011 Jun; 67(6):581-90. PubMed ID: 21318593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm.
    Pei L; Tian X; Long Y; Nan W; Jia M; Qiao R; Zhang J
    Medicine (Baltimore); 2018 Sep; 97(36):e12178. PubMed ID: 30200121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.
    Guo C; Kuang Y; Zhou H; Yuan H; Pei Q; Li J; Jiang W; Ng CM; Chen X; Huo Y; Cui Y; Wang X; Yu J; Sun X; Yu W; Chen P; Miao D; Liu W; Yu Z; Ouyang Z; Shi X; Lv C; Peng Z; Xiong G; Zeng G; Zeng J; Dai H; Peng J; Zhang Y; Xu F; Wu J; Chen X; Gong H; Yang Z; Wu X; Fang Q; Yang L; Li H; Tan H; Huang Z; Tang X; Yang Q; Tu S; Wang X; Xiang Y; Huang J; Wang X; Cai J; Jiang S; Huang L; Peng J; Gong L; Zou C; Yang G
    Circ Genom Precis Med; 2020 Aug; 13(4):e002602. PubMed ID: 32510984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.
    Hirai T; Hamada Y; Geka Y; Kuwana S; Hirai K; Ishibashi M; Fukaya Y; Kimura T
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1491-1497. PubMed ID: 28795244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variations in the transcription factors
    Yee J; Kim W; Chang BC; Chung JE; Lee KE; Gwak HS
    Drug Des Devel Ther; 2019; 13():1717-1727. PubMed ID: 31190750
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
    Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
    Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.
    Zeng WT; Xu Q; Li CH; Chen WY; Sun XT; Wang X; Yang YY; Shi H; Yang ZS
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1327-1334. PubMed ID: 27488389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating genotypes in the SAMe-TT
    Liu J; Wang N; Qin L; Liu J; Xi S; Wang X; Li X; Zhang Y; Yin T
    Int J Cardiol; 2017 Aug; 241():358-363. PubMed ID: 28479094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China.
    Gu Q; Kong Y; Schneede J; Xiao YB; Chen L; Zhong QJ; Wang XF; Hao J; Chen BC; Chen JJ
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1217-27. PubMed ID: 20842355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between
    Yee J; Kim W; Chang BC; Chung JE; Lee KE; Gwak HS
    Pharmacogenomics; 2019 Jun; 20(9):659-667. PubMed ID: 31068094
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.
    Aithal GP; Day CP; Kesteven PJ; Daly AK
    Lancet; 1999 Feb; 353(9154):717-9. PubMed ID: 10073515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
    Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VKORC1 gene polymorphisms and adverse events in Croatian patients on warfarin therapy.
    Mandic D; Bozina N; Mandic S; Samardzija M; Milostic-Srb A; Rumora L
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):905-13. PubMed ID: 26445138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of CYP2C9 gene polymorphism with bleeding as a complication of warfarin therapy.
    Samardzija M; Topić E; Stefanović M; Zibar L; Samardzija G; Balen S; Vcev A; Domanović D; Mirat J; Barbić J
    Coll Antropol; 2008 Jun; 32(2):557-64. PubMed ID: 18756910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of
    Lin X; Chen H; Ni L; Yu Y; Luo Z; Liao L
    Pharmacogenomics; 2020 Aug; 21(12):863-870. PubMed ID: 32559398
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.
    Cho HJ; Sohn KH; Park HM; Lee KH; Choi B; Kim S; Kim JS; On YK; Chun MR; Kim HJ; Kim JW; Lee SY
    Pharmacogenomics; 2007 Apr; 8(4):329-37. PubMed ID: 17391071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.